The projected timeframe until cervical cancer elimination in Australia: a modelling study (Q57058899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

The projected timeframe until cervical cancer elimination in Australia: a modelling study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

main subject

Australia

0 references

cervix uterine cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Kate Simms

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Jie-Bin Lew

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Megan Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Ian Frazer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

8

Karen Canfell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

6

Marion Saville

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

5

Julia Ml Brotherton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

language of work or name

English

0 references

publication date

2 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 April 2020

https://www.thelancet.com/action/showPdf?pii=S2468-2667%2818%2930183-X

0 references

published in

Lancet Public Health

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

e19-e27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

Impact of the Australian National Cervical Screening Program in women of different ages

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Cervical screening in HPV-vaccinated populations.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

HPV vaccine impact in Australian women: ready for an HPV-based screening program

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Rare cancers are not so rare: the rare cancer burden in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2818%2930183-X

7 January 2021

10.1016/S2468-2667(18)30183-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30291040%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference